DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,400 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices.
Summary for Tradename: DEFINITY
Clinical Trials for: DEFINITY
Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
Status: Recruiting Condition: Liver Tumors
3-D Transcranial Ultrasound Analysis Study
Status: Recruiting Condition: Cerebrovascular Accident; Intracranial Hypertension
A Prospective, Phase IV, Surveillance Registry Study to Evaluate the Safety of DEFINITY┬« in Clinical Practice
Status: Completed Condition: Cardiovascular Disease
A Study of Commercial DEFINITY┬« to Monitor the Effects of the Heart's Pulmonary Artery Pressure
Status: Completed Condition: Pulmonary Heart Disease
Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy
Status: Not yet recruiting Condition: Breast Cancer
DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
Status: Completed Condition: Ventricular Ejection Fraction
A Pilot Study of the Effects of Contrast Enhanced Endoscopic Ultrasound on Determining Vascular Involvement in Pancreatic Lesions
Status: Not yet recruiting Condition: Pancreatic Tumors
Effects of Nebivolol on Skeletal Muscle During Exercise in Hypertensive Patients
Status: Recruiting Condition: Hypertension
Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular Age-related Macular Degeneration
Status: Not yet recruiting Condition: Exudative Macular Degeneration; Retinal Hemorrhage
Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke
Status: Terminated Condition: Acute Ischemic Stroke
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Product||Substance||Delist_Flag||Patent Expiration||Exclusivity Expiration|
|INJECTABLE; INTRAVENOUS||021064||Jul 31, 2001||RX||Yes||5,527,521||Y||<disabled>||<disabled>|
|INJECTABLE; INTRAVENOUS||021064||Jul 31, 2001||RX||Yes||5,585,112||Y||<disabled>||<disabled>|
|INJECTABLE; INTRAVENOUS||021064||Jul 31, 2001||RX||Yes||6,033,645||<disabled>||<disabled>|
|The preview shows a limited data set. Complete access is available with a Subscription|
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639